ANT-301

· Anterogen Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANT-301, covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L [Phase 1]

See pricing